Locations:
Min Investment:
Max Investment:
Target Investment:
Master of Business Administration
Bachelor of Arts
2023
2023
Precision chemical editing platform for drugging tough targets. Foundational science from Yu Lab and Cravatt Lab. Series A led by ARCH.
2022 - 2023
2022 - 2023
RNA medicines to treat human disease in ways that were not previously possible.
2021 - 2023
2021 - 2023
Build disruptive lifescience companies.
2017 - 2021
2017 - 2021
Early hire on the CBO/COO team, roles spanning product strategy, partnering, alliance, and IPO/financing to advance medicines against HBV, Flu, HIV, COVID-19, including Sotrovimab (EUA 2021).
2015 - 2017
2015 - 2017
Partnered with PIs and industry executives to identify, validate, and develop promising university technologies for commercialization.
2012 - 2015
2012 - 2015
THL Credit is an alternative asset manager with $3 billion under management and an affiliate of Thomas H. Lee Partners.
2011 - 2012
2011 - 2012
Healthcare, Leveraged Finance
2010 - 2011
2010 - 2011
Global Chemicals Group - Biofuels, Renewables, Agrochemicals, and Petrochemicals.